Torsemide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide
Condition:   Body Weight Changes Interventions:   Drug: CHF Patients: ER Torsemide 40 mg;   Drug: CHF Patients: Furosemide 40 mg Sponsor:   Sarfez Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2018 Category: Research Source Type: clinical trials